News

Granular Loss Costs in Tech-Driven Litigation

Granular Loss Costs in Tech-Driven Litigation

Litigation and the Call for Granularity

Back in the day, we traded stocks and fumbled through numbers without blinking twice about loss costs. But now, this whole tech-enabled litigation game is flipping the insurance sector on its head. Enter Demotech, Inc. and their deep dive into how technology is changing the face of lawsuits. Joseph Petrelli, the brain behind the operation, is sounding the alarm. He says the mushrooming of industrial-scale litigation claims needs a finer brush to paint the real picture of loss costs.

Unpacking the Tech Intrusion

Okay, here’s the scoop. Demotech's research is pulling back the curtain on how litigation’s getting turbocharged by technology. Imagine billboards with flashy ads and online platforms cranking up the heat on claims, plus the sneaky third-party litigation funding giving it all a push. Petrelli, who's been around long enough to remember the world before all this, found out that the legal profession is morphing. And not in a cute way—think alternative business structures and managed services organizations that could be dodging transparency about who's bankrolling what.

"In 2022, our postmortem of failed carriers identified new, annual litigation as the proximate cause of what destroyed them," says Petrelli.

What does this mean for folks pulling the strings—the regulators, legislators, insurers, and other back-room decision makers? It means they’ve got to get hip to a more nuanced take on loss costs. The composite view just doesn’t cut it anymore.

Granularity: The New Normal?

Fast forward to today, and there’s this idea bouncing around: break down each component of a loss cost. Back in the mid-80s, advisory organizations handed out rates and premiums with everything stitched together. But times changed, and since then, the equation's been simple: (Claim Frequency) x (Claim Cost) equals Loss Cost. Fair enough for when things weren't littered with ads and backdoor deals. But in today's landscape, Petrelli argues for a sum-of-the-parts approach.

The Anatomy of a Claim

  • Claim Frequency of Claims Closed without Payment
  • Cost of Closing without Payment
  • Claim Frequency of Litigated Claims
  • Claim Cost of Litigated Claims
  • Claim Frequency of Non-Litigated Claims
  • Claim Cost of Non-Litigated Claims

This all adds up to the Composite Loss Cost. But the kicker is, you can now see how each part drives the whole picture. For anyone in the hot seat making decisions, uncovering these hidden threads might just be the edge they need.

The Stakes for Stakeholders

What keeps insurance folks up at night? The impact of claim transitioning, for one. If you’re staring at reports and just seeing one massive number, there’s a whole narrative you’re missing. It's about pinpointing annual trends component by component to see what's really influencing the market.

Demotech recommends slicing and dicing these categories to figure out where the pressures are coming from. It’s not gonna change the bottom line of the composite number, but it’ll shine a light on the path to getting there. And that’s gold when you're trying to wrap your head around how tech-heavy litigation landscapes are flexing their muscles.

About Demotech's Role

Demotech thinks this is the moment to step up and unravel these complexities. These folks aren't just daydreamers; their Financial Stability Ratings® keep a sharp eye on the sector. And with their role as a recognized statistical rating organization, we're not just talking pie in the sky—this is grounded stuff. Since '85, they've been laying the groundwork for a fair playing field—something much needed in this rapidly evolving game.

In an era where even the straightforward is no longer so, the call for granularity in loss costs resonates loud. Petrelli and his team might just be setting the stage for how insurers, regulators, and everyone tangled up in this snarl move forward, armed with clarity and precision.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Mobix Labs Innovates AI Drone Solutions for Rail Industry Growth

Updated Category News Views 129

Mobix Labs Secures AI Drone Contract Mobix Labs, Inc. (NASDAQ: MOBX), a leading provider in advanced connectivity and sensing solutions, has embarked on an exciting journey with a new contract for its Mobix Labs Wireless division, RaGE Systems. They are set to develop cutting-edge drone-based, AI-powered inspection technology specifically for the U.S. rail industry. This...

Continue Reading
Lactiga Secures NIH Grant for Groundbreaking Antibody Development

Updated Category News Views 122

Groundbreaking NIH Grant for Lactiga's Antibody Research Lactiga US, Inc., a pioneering biotechnology firm, has secured an important award from the National Institutes of Health (NIH) to enhance the development of its first-in-class secretory IgA (sIgA) antibody targeting inflammatory bowel disease (IBD). Understanding the Power of Breastmilk-Derived Antibodies This...

Continue Reading
Transforming the Intelligent Electronic Devices Market Landscape

Updated Category News Views 231

Market Growth Overview of Intelligent Electronic Devices The Intelligent Electronic Devices (IED) market is on an impressive trajectory, expected to reach USD 33.49 Billion, increasing significantly from its valuation of USD 14.35 Billion in the near future. This growth reflects a compound annual growth rate (CAGR) of 11.18% between now and 2032. The exciting advancements...

Continue Reading
Three Undervalued Energy Stocks Poised For Recovery Ahead

Updated Category News Views 100

Exploring Undervalued Energy Stocks for Portfolio Growth As market conditions fluctuate, the energy sector presents intriguing opportunities for investors seeking to enhance their portfolios. With numerous stocks labeled as oversold, there is potential for significant gains. Seeking out undervalued stocks could be a wise strategy, especially those showing a relative...

Continue Reading
Explore the Latest Blush Shades from Pixi Beauty's Range

Updated Category News Views 173

Pixi Beauty Introduces Three New Blush Shades Pixi Beauty has recently expanded its popular On-the-Glow Blush collection by adding three exciting new shades: Mauve, Cassis, and Chantilly. These versatile colors are designed to streamline beauty routines with a multi-use balm that enhances your natural beauty effortlessly. The Shift Toward Natural Beauty As the beauty...

Continue Reading